Black Diamond Therapeutics, Inc. — Form D
Black Diamond Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-22. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-08-22
- Form: D
- Accession: 0001701541-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2018-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-319777
Issuer
- Name: Black Diamond Therapeutics, Inc.
- CIK: 0001701541
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 139 MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 617-252-0848
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Elizabeth E Buck | Executive Officer | Stony Brook, NY |
| Rajeev M Shah | Director | Boston, MA |
| Ali M Behbahani | Director | Minneapolis, MN |
| Thomas M Leggett | Executive Officer | Cambridge, MA |
| Brent M Hatzis-Schoch | Executive Officer | Cambridge, MA |
| Christopher M Roberts | Executive Officer | Cambridge, MA |
| Garry M Menzel | Director | Cambridge, MA |
| Bradley M Bolzon | Director | Cambridge, MA |
| Samarth M Kulkarni | Director | Cambridge, MA |
| Fang M Ni | Executive Officer | Cambridge, MA |
| Brent E Hatzis-Schoch | Executive Officer | Cambridge, MA |
| Elizabeth M Buck | Executive Officer | Stony Brook, NY |
| Garry E Menzel | Director | Stony Brook, NY |
| David M Epstein | Director | Stony Brook, NY |
| David M Epstein | Executive Officer | Stony Brook, NY |
| Brad E Bolzon | Director | Stony Brook, NY |
| Alexander M Mayweg | Director | Stony Brook, NY |
Other filings by this issuer (5)
More